Aldosterone escape during blockade of the renin–angiotensin–aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2004-11

AUTHORS

K. J. Schjoedt, S. Andersen, P. Rossing, L. Tarnow, H.-H. Parving

ABSTRACT

AIMS/HYPOTHESIS: It has been suggested that aldosterone plays a role in the initiation and progression of renal disease independently of arterial blood pressure and plasma angiotensin II levels. We evaluated the influence of plasma aldosterone levels on progression of diabetic nephropathy during long-term blockade of the renin-angiotensin-aldosterone system. METHODS: A total of 63 hypertensive patients with type 1 diabetes and diabetic nephropathy were treated with losartan, 100 mg once daily, for a mean follow-up period of 35 months. Plasma aldosterone, GFR, albuminuria and 24-h blood pressure were determined at baseline and at regular intervals during the study. RESULTS: Patients were divided according to their increasing or decreasing levels of plasma aldosterone during long-term losartan treatment in an escape group (n=26) and a non-escape group (n=37). In the escape group, aldosterone levels increased from (geometric mean [95% CI]) 57 pg/ml (43-76 pg/ml) at 2 months, to 102 pg/ml (78-134 pg/ml) at the end of the study (p<0.01). The corresponding levels in the non-escape group were 83 pg/ml (69-102 pg/ml) and 49 pg/ml (40-60 pg/ml; p<0.01). The median rate of decline in GFR was 5.0 ml.min(-1).year(-1) (range 0.4-15.9 ml.min(-1).year(-1)) in the escape group, compared with 2.4 ml.min(-1).year(-1) (-1.6 to 11.0 ml.min(-1).year(-1)) in the non-escape group (p<0.005). The increase in plasma aldosterone correlated with the rate of decline in GFR (r(2)=0.19, p<0.001), corresponding to a decline in GFR of 1.5 ml.min(-1).year(-1) for every two-fold increase in plasma aldosterone. Pre-treatment and treatment values of plasma aldosterone were not related to albuminuria or to changes in albuminuria during the study. CONCLUSIONS/INTERPRETATION: Our data suggest that aldosterone escape during long-term blockade of the renin-angiotensin-aldosterone system is associated with an enhanced decline in GFR in patients with type 1 diabetes and diabetic nephropathy. More... »

PAGES

1936-1939

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00125-004-1542-0

DOI

http://dx.doi.org/10.1007/s00125-004-1542-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050556439

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15551047


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Albuminuria", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aldosterone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Creatinine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Nephropathies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dietary Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glomerular Filtration Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycated Hemoglobin A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Losartan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Potassium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Renin-Angiotensin System", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sodium", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Steno Diabetes Center", 
          "id": "https://www.grid.ac/institutes/grid.419658.7", 
          "name": [
            "Steno Diabetes Center, Niels Steensens Vej 2, 2820, Gentofte, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schjoedt", 
        "givenName": "K. J.", 
        "id": "sg:person.0623062715.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623062715.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Steno Diabetes Center", 
          "id": "https://www.grid.ac/institutes/grid.419658.7", 
          "name": [
            "Steno Diabetes Center, Niels Steensens Vej 2, 2820, Gentofte, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Andersen", 
        "givenName": "S.", 
        "id": "sg:person.0617626413.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617626413.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Steno Diabetes Center", 
          "id": "https://www.grid.ac/institutes/grid.419658.7", 
          "name": [
            "Steno Diabetes Center, Niels Steensens Vej 2, 2820, Gentofte, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rossing", 
        "givenName": "P.", 
        "id": "sg:person.01036424445.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036424445.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Steno Diabetes Center", 
          "id": "https://www.grid.ac/institutes/grid.419658.7", 
          "name": [
            "Steno Diabetes Center, Niels Steensens Vej 2, 2820, Gentofte, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tarnow", 
        "givenName": "L.", 
        "id": "sg:person.01227640403.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227640403.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Aarhus University", 
          "id": "https://www.grid.ac/institutes/grid.7048.b", 
          "name": [
            "Steno Diabetes Center, Niels Steensens Vej 2, 2820, Gentofte, Denmark", 
            "Faculty of Health Science, University of Aarhus, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Parving", 
        "givenName": "H.-H.", 
        "id": "sg:person.01036362324.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036362324.03"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1161/01.hyp.0000044937.95080.e9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005454110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001648-199001000-00010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008096418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001648-199001000-00010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008096418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0895-7061(02)02333-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011300828"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(01)01237-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019175381"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.100.10.1056", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032045567"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1046/j.1523-1755.2001.0590041432.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038973677", 
          "https://doi.org/10.1046/j.1523-1755.2001.0590041432.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.26.5.1501", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046333007"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(90)90878-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047398664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(90)90878-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047398664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-200105000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051337066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00004872-200105000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051337066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/014107680109400803", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074851648"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/014107680109400803", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074851648"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2004-11", 
    "datePublishedReg": "2004-11-01", 
    "description": "AIMS/HYPOTHESIS: It has been suggested that aldosterone plays a role in the initiation and progression of renal disease independently of arterial blood pressure and plasma angiotensin II levels. We evaluated the influence of plasma aldosterone levels on progression of diabetic nephropathy during long-term blockade of the renin-angiotensin-aldosterone system.\nMETHODS: A total of 63 hypertensive patients with type 1 diabetes and diabetic nephropathy were treated with losartan, 100 mg once daily, for a mean follow-up period of 35 months. Plasma aldosterone, GFR, albuminuria and 24-h blood pressure were determined at baseline and at regular intervals during the study.\nRESULTS: Patients were divided according to their increasing or decreasing levels of plasma aldosterone during long-term losartan treatment in an escape group (n=26) and a non-escape group (n=37). In the escape group, aldosterone levels increased from (geometric mean [95% CI]) 57 pg/ml (43-76 pg/ml) at 2 months, to 102 pg/ml (78-134 pg/ml) at the end of the study (p<0.01). The corresponding levels in the non-escape group were 83 pg/ml (69-102 pg/ml) and 49 pg/ml (40-60 pg/ml; p<0.01). The median rate of decline in GFR was 5.0 ml.min(-1).year(-1) (range 0.4-15.9 ml.min(-1).year(-1)) in the escape group, compared with 2.4 ml.min(-1).year(-1) (-1.6 to 11.0 ml.min(-1).year(-1)) in the non-escape group (p<0.005). The increase in plasma aldosterone correlated with the rate of decline in GFR (r(2)=0.19, p<0.001), corresponding to a decline in GFR of 1.5 ml.min(-1).year(-1) for every two-fold increase in plasma aldosterone. Pre-treatment and treatment values of plasma aldosterone were not related to albuminuria or to changes in albuminuria during the study.\nCONCLUSIONS/INTERPRETATION: Our data suggest that aldosterone escape during long-term blockade of the renin-angiotensin-aldosterone system is associated with an enhanced decline in GFR in patients with type 1 diabetes and diabetic nephropathy.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00125-004-1542-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "47"
      }
    ], 
    "name": "Aldosterone escape during blockade of the renin\u2013angiotensin\u2013aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate", 
    "pagination": "1936-1939", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f0d5f5073e7e8fb70c45da2f837ba54a30fb8121c80d744b4d6accc9681df998"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15551047"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0006777"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00125-004-1542-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050556439"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00125-004-1542-0", 
      "https://app.dimensions.ai/details/publication/pub.1050556439"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000348_0000000348/records_54319_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00125-004-1542-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00125-004-1542-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00125-004-1542-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00125-004-1542-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00125-004-1542-0'


 

This table displays all metadata directly associated to this object as RDF triples.

208 TRIPLES      21 PREDICATES      58 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00125-004-1542-0 schema:about N01b21589dfcf49c8a821d53b0d785df4
2 N031f00cf14314d93b3ae532fbd7f22ea
3 N0a4719b928584a5087ad39d472cfd72a
4 N111bccf287e648548ee6b4e88bea47d8
5 N16e33ba9b89a4bc5a48442a1ecc61a55
6 N5622b666637f48d28720bfc4402ce2c8
7 N59c830301c784557a6e2b0d03d0fb415
8 N8019920fb5f14e2fbb8d4ab791a449d5
9 N85ca92c6658b4d9982d0a055086ed76d
10 N89267de2b7de40719f378fbb2ec599e9
11 N8b3620e37703417d8c7b00a450832e46
12 N9160d921d8f447b8aba9f8af86731798
13 N970e011cee04443b9b4e3af71eb709da
14 Na36711ddc9c8447287c276dc42ade138
15 Nb6c242c7b7604ee993b647c78f8fc72b
16 Nca3e1eadb37a4b3fb0fc09e9b62b16a7
17 Nf02dd528f1b34ae7a0f437de6e8c693b
18 Nf0a1fad8cf094549811d1b3f5aaa45ce
19 Nfb8827a86eab4da8a010370a508040de
20 anzsrc-for:11
21 anzsrc-for:1103
22 schema:author N6b90d46bbd104a14b582b70f0e825933
23 schema:citation sg:pub.10.1046/j.1523-1755.2001.0590041432.x
24 https://doi.org/10.1016/0140-6736(90)90878-9
25 https://doi.org/10.1016/s0735-1097(01)01237-2
26 https://doi.org/10.1016/s0895-7061(02)02333-6
27 https://doi.org/10.1097/00001648-199001000-00010
28 https://doi.org/10.1097/00004872-200105000-00001
29 https://doi.org/10.1161/01.cir.100.10.1056
30 https://doi.org/10.1161/01.hyp.0000044937.95080.e9
31 https://doi.org/10.1177/014107680109400803
32 https://doi.org/10.2337/diacare.26.5.1501
33 schema:datePublished 2004-11
34 schema:datePublishedReg 2004-11-01
35 schema:description AIMS/HYPOTHESIS: It has been suggested that aldosterone plays a role in the initiation and progression of renal disease independently of arterial blood pressure and plasma angiotensin II levels. We evaluated the influence of plasma aldosterone levels on progression of diabetic nephropathy during long-term blockade of the renin-angiotensin-aldosterone system. METHODS: A total of 63 hypertensive patients with type 1 diabetes and diabetic nephropathy were treated with losartan, 100 mg once daily, for a mean follow-up period of 35 months. Plasma aldosterone, GFR, albuminuria and 24-h blood pressure were determined at baseline and at regular intervals during the study. RESULTS: Patients were divided according to their increasing or decreasing levels of plasma aldosterone during long-term losartan treatment in an escape group (n=26) and a non-escape group (n=37). In the escape group, aldosterone levels increased from (geometric mean [95% CI]) 57 pg/ml (43-76 pg/ml) at 2 months, to 102 pg/ml (78-134 pg/ml) at the end of the study (p<0.01). The corresponding levels in the non-escape group were 83 pg/ml (69-102 pg/ml) and 49 pg/ml (40-60 pg/ml; p<0.01). The median rate of decline in GFR was 5.0 ml.min(-1).year(-1) (range 0.4-15.9 ml.min(-1).year(-1)) in the escape group, compared with 2.4 ml.min(-1).year(-1) (-1.6 to 11.0 ml.min(-1).year(-1)) in the non-escape group (p<0.005). The increase in plasma aldosterone correlated with the rate of decline in GFR (r(2)=0.19, p<0.001), corresponding to a decline in GFR of 1.5 ml.min(-1).year(-1) for every two-fold increase in plasma aldosterone. Pre-treatment and treatment values of plasma aldosterone were not related to albuminuria or to changes in albuminuria during the study. CONCLUSIONS/INTERPRETATION: Our data suggest that aldosterone escape during long-term blockade of the renin-angiotensin-aldosterone system is associated with an enhanced decline in GFR in patients with type 1 diabetes and diabetic nephropathy.
36 schema:genre research_article
37 schema:inLanguage en
38 schema:isAccessibleForFree true
39 schema:isPartOf Nac5f570f2374403cbc923279a7d18b17
40 Nb70ff2a8d366431d906556ac88b10bc6
41 sg:journal.1001482
42 schema:name Aldosterone escape during blockade of the renin–angiotensin–aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate
43 schema:pagination 1936-1939
44 schema:productId N2dbe8deedadf4780a0ce239bb56627a2
45 N33c5996180c747c29795edf499a65b76
46 Nab1959783c214ec4b42f938bffd38b42
47 Nfc9d4fda80e242268d5ed8124b30ee32
48 Nfd61bafb2ca142369d9bfab10978e37c
49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050556439
50 https://doi.org/10.1007/s00125-004-1542-0
51 schema:sdDatePublished 2019-04-11T10:18
52 schema:sdLicense https://scigraph.springernature.com/explorer/license/
53 schema:sdPublisher N0420402daf424a20a9ba2d497d65e6ac
54 schema:url https://link.springer.com/10.1007%2Fs00125-004-1542-0
55 sgo:license sg:explorer/license/
56 sgo:sdDataset articles
57 rdf:type schema:ScholarlyArticle
58 N01b21589dfcf49c8a821d53b0d785df4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Aldosterone
60 rdf:type schema:DefinedTerm
61 N031f00cf14314d93b3ae532fbd7f22ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Adult
63 rdf:type schema:DefinedTerm
64 N0420402daf424a20a9ba2d497d65e6ac schema:name Springer Nature - SN SciGraph project
65 rdf:type schema:Organization
66 N0a4719b928584a5087ad39d472cfd72a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Female
68 rdf:type schema:DefinedTerm
69 N111bccf287e648548ee6b4e88bea47d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Sodium
71 rdf:type schema:DefinedTerm
72 N16e33ba9b89a4bc5a48442a1ecc61a55 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Potassium
74 rdf:type schema:DefinedTerm
75 N2dbe8deedadf4780a0ce239bb56627a2 schema:name pubmed_id
76 schema:value 15551047
77 rdf:type schema:PropertyValue
78 N33c5996180c747c29795edf499a65b76 schema:name nlm_unique_id
79 schema:value 0006777
80 rdf:type schema:PropertyValue
81 N5622b666637f48d28720bfc4402ce2c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Glomerular Filtration Rate
83 rdf:type schema:DefinedTerm
84 N59c830301c784557a6e2b0d03d0fb415 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Diabetic Nephropathies
86 rdf:type schema:DefinedTerm
87 N6b90d46bbd104a14b582b70f0e825933 rdf:first sg:person.0623062715.35
88 rdf:rest Na7eb895af97a4182b766e9b3713d1280
89 N8019920fb5f14e2fbb8d4ab791a449d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Losartan
91 rdf:type schema:DefinedTerm
92 N85ca92c6658b4d9982d0a055086ed76d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Male
94 rdf:type schema:DefinedTerm
95 N864fe0d76d834ef19bab02b03febf1d8 rdf:first sg:person.01227640403.97
96 rdf:rest Nbde7a03b46334ce590e100ca49053314
97 N89267de2b7de40719f378fbb2ec599e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Humans
99 rdf:type schema:DefinedTerm
100 N8b3620e37703417d8c7b00a450832e46 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Diabetes Mellitus, Type 1
102 rdf:type schema:DefinedTerm
103 N8bde0ea9456144fea0a5c8aab0cc439d rdf:first sg:person.01036424445.54
104 rdf:rest N864fe0d76d834ef19bab02b03febf1d8
105 N9160d921d8f447b8aba9f8af86731798 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Glycated Hemoglobin A
107 rdf:type schema:DefinedTerm
108 N970e011cee04443b9b4e3af71eb709da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Dietary Proteins
110 rdf:type schema:DefinedTerm
111 Na36711ddc9c8447287c276dc42ade138 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Creatinine
113 rdf:type schema:DefinedTerm
114 Na7eb895af97a4182b766e9b3713d1280 rdf:first sg:person.0617626413.63
115 rdf:rest N8bde0ea9456144fea0a5c8aab0cc439d
116 Nab1959783c214ec4b42f938bffd38b42 schema:name doi
117 schema:value 10.1007/s00125-004-1542-0
118 rdf:type schema:PropertyValue
119 Nac5f570f2374403cbc923279a7d18b17 schema:issueNumber 11
120 rdf:type schema:PublicationIssue
121 Nb6c242c7b7604ee993b647c78f8fc72b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Middle Aged
123 rdf:type schema:DefinedTerm
124 Nb70ff2a8d366431d906556ac88b10bc6 schema:volumeNumber 47
125 rdf:type schema:PublicationVolume
126 Nbde7a03b46334ce590e100ca49053314 rdf:first sg:person.01036362324.03
127 rdf:rest rdf:nil
128 Nca3e1eadb37a4b3fb0fc09e9b62b16a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Renin-Angiotensin System
130 rdf:type schema:DefinedTerm
131 Nf02dd528f1b34ae7a0f437de6e8c693b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Blood Pressure
133 rdf:type schema:DefinedTerm
134 Nf0a1fad8cf094549811d1b3f5aaa45ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Albuminuria
136 rdf:type schema:DefinedTerm
137 Nfb8827a86eab4da8a010370a508040de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Antihypertensive Agents
139 rdf:type schema:DefinedTerm
140 Nfc9d4fda80e242268d5ed8124b30ee32 schema:name dimensions_id
141 schema:value pub.1050556439
142 rdf:type schema:PropertyValue
143 Nfd61bafb2ca142369d9bfab10978e37c schema:name readcube_id
144 schema:value f0d5f5073e7e8fb70c45da2f837ba54a30fb8121c80d744b4d6accc9681df998
145 rdf:type schema:PropertyValue
146 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
147 schema:name Medical and Health Sciences
148 rdf:type schema:DefinedTerm
149 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
150 schema:name Clinical Sciences
151 rdf:type schema:DefinedTerm
152 sg:journal.1001482 schema:issn 0012-186X
153 1432-0428
154 schema:name Diabetologia
155 rdf:type schema:Periodical
156 sg:person.01036362324.03 schema:affiliation https://www.grid.ac/institutes/grid.7048.b
157 schema:familyName Parving
158 schema:givenName H.-H.
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036362324.03
160 rdf:type schema:Person
161 sg:person.01036424445.54 schema:affiliation https://www.grid.ac/institutes/grid.419658.7
162 schema:familyName Rossing
163 schema:givenName P.
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036424445.54
165 rdf:type schema:Person
166 sg:person.01227640403.97 schema:affiliation https://www.grid.ac/institutes/grid.419658.7
167 schema:familyName Tarnow
168 schema:givenName L.
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227640403.97
170 rdf:type schema:Person
171 sg:person.0617626413.63 schema:affiliation https://www.grid.ac/institutes/grid.419658.7
172 schema:familyName Andersen
173 schema:givenName S.
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617626413.63
175 rdf:type schema:Person
176 sg:person.0623062715.35 schema:affiliation https://www.grid.ac/institutes/grid.419658.7
177 schema:familyName Schjoedt
178 schema:givenName K. J.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623062715.35
180 rdf:type schema:Person
181 sg:pub.10.1046/j.1523-1755.2001.0590041432.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038973677
182 https://doi.org/10.1046/j.1523-1755.2001.0590041432.x
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1016/0140-6736(90)90878-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047398664
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1016/s0735-1097(01)01237-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019175381
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/s0895-7061(02)02333-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011300828
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1097/00001648-199001000-00010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008096418
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1097/00004872-200105000-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051337066
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1161/01.cir.100.10.1056 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032045567
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1161/01.hyp.0000044937.95080.e9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005454110
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1177/014107680109400803 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074851648
199 rdf:type schema:CreativeWork
200 https://doi.org/10.2337/diacare.26.5.1501 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046333007
201 rdf:type schema:CreativeWork
202 https://www.grid.ac/institutes/grid.419658.7 schema:alternateName Steno Diabetes Center
203 schema:name Steno Diabetes Center, Niels Steensens Vej 2, 2820, Gentofte, Denmark
204 rdf:type schema:Organization
205 https://www.grid.ac/institutes/grid.7048.b schema:alternateName Aarhus University
206 schema:name Faculty of Health Science, University of Aarhus, Denmark
207 Steno Diabetes Center, Niels Steensens Vej 2, 2820, Gentofte, Denmark
208 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...